Given our observations that MIF and DDT gene expression levels do not correlate with melanoma subtype or mutational status and that high CD74:MIF and CD74:DDT expression level ratios correspond with enhanced intratumoral immune cell infiltration, clinical targeting of MIF and DDT holds potential to be effective across subtypes and mutational status. This evidence concerns the gene CD74 and melanoma.